Phytocannabinoid Prodrugs and Semisynthetic Cannabinoids
Chemické listy · 15.06.2026 · 120 (6) · 306-313
DOI: 10.54779/chl20260306 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemické listy, online erschienen am 15.06.2026. Verfasst von Stanislav Rádl. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cannabinoids, both phytocannabinoids and synthetic cannabinoids, represent significant potential in the treatment of various diseases. The problematic bioavailability of phytocannabinoids could be improved by developing their prodrugs, which is discussed in the first part of this review. The second part is devoted to the so-called semi-synthetic cannabinoids, a rapidly growing group of substances developed mainly to circumvent the legislative restrictions on some phytocannabinoids, especially Δ9-tetrahydrocannabinol (THC). The final part highlights the frequent errors on websites related to the recreational use of cannabinoids.
Zitieren
APA
Rádl, S. (2026). Phytocannabinoid Prodrugs and Semisynthetic Cannabinoids. Chemické listy, 120(6), 306-313. https://doi.org/10.54779/chl20260306
Vancouver
Rádl S. Phytocannabinoid Prodrugs and Semisynthetic Cannabinoids. Chemické listy. 2026;120(6):306-313. doi:10.54779/chl20260306
BibTeX
@article{Rdl2026,
author = {Rádl, Stanislav},
title = {Phytocannabinoid Prodrugs and Semisynthetic Cannabinoids},
journal = {Chemické listy},
year = {2026},
volume = {120},
number = {6},
pages = {306--313},
doi = {10.54779/chl20260306}
}
EUVIMED